Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy

Active, not recruitingOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

January 1, 2025

Study Completion Date

December 18, 2029

Conditions
NSCLC
Trial Locations (22)

7609 PP

Ziekenhuisgroep Twente, Almelo

7334 DZ

Gelre ziekenhuis, Apeldoorn

6815 AD

Radiotherapiegroep Arnhem, Arnhem

Rijnstate, Arnhem

7416 SE

Deventer Hospital, Deventer

6716 RP

Gelderse Vallei, Ede

5623 EJ

Catharina Ziekenhuis, Eindhoven

5631 BM

Máxima MC, Eindhoven

7500 KA

Medisch Spectrum Twente, Enschede

4200 AB

Rivas Zorggroep, Gorinchem

2803 HH

Groen Hart Ziekenhuis, Gouda

6419 PC

Zuyderland, Heerlen

6229 ET

Maastro, Maastricht

6229 HX

MUMC+, Maastricht

6532 SZ

Canisius-Wilhelmina Hospital, Nijmegen

6043 VC

Laurentius Hospital, Roermond

3079 DZ

Maasstad Ziekenhuis, Rotterdam

3083 AN

Ikazia Ziekenhuis, Rotterdam

2504 LN

Haga Ziekenhuis, The Hague

2512 VA

Haaglanden MC, The Hague

5912 BL

VieCuri MC, Venlo

1502 DV

Zaans MC, Zaandam

Sponsors
All Listed Sponsors
collaborator

Dutch Society of Physicians for Pulmonology and Tuberculosis

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

VieCuri Medical Centre

OTHER

collaborator

AstraZeneca

INDUSTRY

collaborator

Dutch Cancer Society

OTHER

lead

Maastricht Radiation Oncology

OTHER